Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PTGER4 | P35408 | 2/20 | 0.38 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | GRM5 | P41594 | 2/20 | 0.35 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.35 |
| ▸ | IMPDH2 | P12268 | 1/20 | 0.34 |
| ▸ | METAP2 | P50579 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.33 |
| ▸ | CA2 | P00918 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | POLB | P06746 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | HPGD | P15428 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | RORC | P51449 | 1/20 | 0.32 |
| ▸ | PGR | P06401 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20086156 | 0.90 | PTGER4 (0.44) | PTGER4ENPP3IMPDH2METAP2CA1 | |
| SCHEMBL22679437 | 0.89 | MAP4K4 (0.42) | GRM5TSHRADORA2AKDM4EMEN1 | |
| SCHEMBL21710574 | 0.89 | PTGER4 (0.40) | PTGER4CYP19A1ENPP3CA1CA2 | |
| SCHEMBL20086148 | 0.88 | KDM4E (0.36) | PTGER4CYP19A1ENPP3KDM4EALDH1A1 | |
| SCHEMBL23898598 | 0.88 | L3MBTL1 (0.37) | CYP19A1CA1CA2MEN1ALDH1A1 | |
| SCHEMBL16621686 | 0.86 | CYP19A1 (0.38) | PTGER4CYP19A1METAP2TSHRADORA2A | |
| SCHEMBL16621695 | 0.86 | CYP19A1 (0.38) | PTGER4CYP19A1METAP2TSHRADORA2A | |
| SCHEMBL16621724 | 0.85 | CYP19A1 (0.38) | PTGER4CYP19A1METAP2TSHRADORA2A | |
| SCHEMBL16621708 | 0.85 | CYP19A1 (0.38) | PTGER4CYP19A1METAP2TSHRADORA2A | |
| SCHEMBL10153493 | 0.84 | GPR3 (0.42) | CYP19A1TSHRKDM4EMEN1ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10714694-B2 | Delayed fluorescence material and organic light emitting device having the delayed fluorescence material | Research & Business Foundation Sungkyunkwan University (KR) | 2020-07-14 | — | — | US | disclosed |
| US-20180114924-A1 | DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT EMITTING DEVICE HAVING THE DELAYED FLUORESCENCE MATERIAL | Research & Business Foundation Sungkyunkwan University (KR) | 2018-04-26 | — | — | US | disclosed |
| US-20180114924-A1 | DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT EMITTING DEVICE HAVING THE DELAYED FLUORESCENCE MATERIAL | Research & Business Foundation Sungkyunkwan University (KR) | 2018-04-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180114924-A1 | DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT EMITTING DEVICE HAVING THE DELAYED FLUORESCENCE MATERIAL | GFPT1, ETFA, TFEB | PTGER4 4130/4885CYP19A1 3633/4885GRM5 2834/4885 |
| US-10714694-B2 | Delayed fluorescence material and organic light emitting device having the delayed fluorescence material | GFPT1, ETFA, TFEB | PTGER4 4130/4885CYP19A1 3633/4885GRM5 2834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.